Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Replimune Group, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- −14 vs. Q2 2023
- Shares held
- 56.8M
- +2.21M (+4.0%) vs. Q2 2023
- Total value
- $970.9M
- −$296.4M (−23.4%) vs. Q2 2023
- New holders
- 9
- 51 more added
- Sold out
- 23
- 42 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REPL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 199 | $1.06B |
| Q1 2026 | 180 | $619.2M |
| Q4 2025 | 165 | $775.2M |
| Q3 2025 | 163 | $347.5M |
| Q2 2025 | 175 | $752.1M |
| Q1 2025 | 167 | $799.3M |
| Q4 2024 | 157 | $943.2M |
| Q3 2024 | 144 | $766.7M |
| Q2 2024 | 149 | $638.1M |
| Q1 2024 | 150 | $547.8M |
| Q4 2023 | 140 | $556.8M |
| Q3 2023 | 127 | $970.9M |
| Q2 2023 | 141 | $1.27B |
| Q1 2023 | 140 | $949.0M |
| Q4 2022 | 135 | $1.31B |
| Q3 2022 | 106 | $703.9M |
| Q2 2022 | 102 | $700.2M |
| Q1 2022 | 107 | $665.0M |
| Q4 2021 | 99 | $1.05B |
| Q3 2021 | 101 | $1.05B |
| Q2 2021 | 110 | $1.34B |
| Q1 2021 | 108 | $1.06B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Replimune Group, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Braidwell LP | 487,520 | $8.34M | 0.26% | 00.0% | Unchanged |
| Artal Group S.A. | 500,000 | $8.55M | 0.37% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 503,844 | $8.62M | 0.60% | +154,955+44.4% | Added |
| Amundi | 582,088 | $8.87M | 0.00% | +130,041+28.8% | Added |
| Goldman Sachs Group Inc | 559,330 | $9.57M | 0.00% | −53,443−8.7% | Reduced |
| Candriam Luxembourg S.C.A. | 612,193 | $10.5M | 0.09% | 00.0% | Unchanged |
| Great Point Partners LLC | 638,495 | $10.9M | 2.06% | +638,495 | New |
| Marshall Wace, LLP | 689,453 | $11.8M | 0.03% | −543,771−44.1% | Reduced |
| T. Rowe Price Investment Management, Inc. | 727,610 | $12.4M | 0.01% | 00.0% | Unchanged |
| Emerald Mutual Fund Advisers Trust | 874,210 | $15.0M | 0.90% | −26,742−3.0% | Reduced |
| Geode Capital Management, LLC | 1,008,343 | $17.3M | 0.00% | +207,515+25.9% | Added |
| Emerald Advisers, LLC | 1,052,524 | $18.0M | 0.87% | −33,763−3.1% | Reduced |
| Citadel Advisors LLC | 1,197,035 | $20.5M | 0.02% | +60,917+5.4% | Added |
| FMR LLC | 1,268,683 | $21.7M | 0.00% | −275,885−17.9% | Reduced |
| Loomis Sayles & Co L P | 1,290,450 | $22.1M | 0.04% | +103,223+8.7% | Added |
| Dimensional Fund Advisors LP | 1,430,025 | $24.5M | 0.01% | +145,576+11.3% | Added |
| Camber Capital Management LP | 2,000,000 | $34.2M | 1.23% | +450,000+29.0% | Added |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35.9M | 5.56% | 00.0% | Unchanged |
| BVF Inc | 2,143,036 | $36.7M | 0.99% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 2,166,992 | $37.1M | 0.02% | +2,149,008+11,949.6% | Added |
| State Street Corp | 2,370,645 | $40.6M | 0.00% | +281,664+13.5% | Added |
| Vanguard Group Inc | 2,596,119 | $44.4M | 0.00% | +242,220+10.3% | Added |
| Omega Fund Management, LLC | 3,001,319 | $51.4M | 47.17% | 00.0% | Unchanged |
| BlackRock Inc. | 3,957,946 | $67.7M | 0.00% | +463,900+13.3% | Added |
| Redmile Group, LLC | 4,163,922 | $71.2M | 3.39% | −256,611−5.8% | Reduced |
| Baker Bros. Advisors LP | 4,578,280 | $78.3M | 0.45% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 5,793,199 | $99.1M | 0.01% | +60,187+1.0% | Added |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −182,111−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −116,469−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −106,808−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −80,564−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −58,268−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −57,120−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −50,663−100.0% | Sold out |
| Resolute Capital Asset Partners LLC | 0 | $0 | 0.00% | −43,977−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −28,837−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −25,298−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −18,607−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −18,170−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −17,417−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −11,290−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −10,865−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −10,344−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −9,037−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −11,501−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −3,030−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |